Search for the latest updates on diabetes
News
PhaseBio Pharmaceuticals Announces Positive Data for Type 2 Diabetes Treatments PE0139 and PB1023 GlobeNewswire via Yahoo! Finance - 41 minutes
PE0139 was well tolerated; pharmacokinetic / pharmacodynamic profile supports once-weekly dosing PE0139 demonstrated synergistic action with ...
Manage alerts · Privacy Policy
Tip: To search for an exact phrase, put quotation marks around two or more words.
| You received this email because you subscribed to Yahoo! Search. |
No comments:
Post a Comment